Ask yourself 1) why has ATH engaged a specialist Coy to give them a true picture re proposed annual Revenue in July ? Is it so they can use that figure when negotiating a Partnership or a Take Over. 2)pre AA talks with FDA in October then another meeting in December. 3)All results were better than Placebo 4)15 Interested Pharmas 5)Final results in July 6)roadshow which includes Prof DC in August 7)Manufacture found 8) Ath want to keep control of Partnership 9)Most important is that the trial with 170 sufferers the agreed end point will be of clinical benefit using umsars ..
ATH Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)